E-LIB Suche - Ergebnisse für: Tedeschi, A.

1

TELEMONITORING IN PATIENTS WITH CHRONIC HEART FAILURE: EXPE..:

Novara, P ; Matrone, B ; Di Spigno, F...
European Heart Journal Supplements. 26 (2024) Supplement_2 - p. ii23-ii23 , 2024

Link: https://doi.org/10.1093/..

2

TELECUORE: FEASIBILITY OF A HOSPITAL–TERRITORIAL TELEMEDICI..:

Matrone, B ; Novara, P ; Di Spigno, F...
European Heart Journal Supplements. 26 (2024) Supplement_2 - p. ii102-ii102 , 2024

Link: https://doi.org/10.1093/..

3

SARS–COV2 INFECTIONS IN HEART TRANSPLANT RECIPIENTS: VACCIN..:

Tedeschi, A ; Ammirati, E ; Garascia, A...
European Heart Journal Supplements. 26 (2024) Supplement_2 - p. ii91-ii91 , 2024

Link: https://doi.org/10.1093/..

4

THE GLA D313Y MUTATION IN FABRY DISEASE: DIAGNOSTIC DILEMMA..:

Dall'Ospedale, V ; Valsania, T ; Di Spigno, F...
European Heart Journal Supplements. 26 (2024) Supplement_2 - p. ii191-ii192 , 2024

Link: https://doi.org/10.1093/..

5

Axion Dark Matter eXperiment: Run 1A analysis details:

Boutan, C. ; LaRoque, B. H. ; Lentz, E....
Physical Review D. 109 (2024) 1 - p. , 2024

Link: https://doi.org/10.1103/..

6

TRANSIENT GLOBAL AMNESIA AND CONCOMITANT TAKOTSUBO CARDIOMY..:

Borsi, L ; Di Spigno, F ; Biagi, A...
European Heart Journal Supplements. 26 (2024) Supplement_2 - p. ii201-ii201 , 2024

Link: https://doi.org/10.1093/..

7

FIXED‐DURATION IBRUTINIB + VENETOCLAX IN CHRONIC LYMPHOCYTI..:

Ghia, P. ; Allan, J. N. ; Siddiqi, T....
Hematological Oncology. 41 (2023) S2 - p. 238-239 , 2023

Link: https://doi.org/10.1002/..

8

Ibrutinib (Ibr) dose modification for management of early c..:

Tedeschi, A. ; Ahn, I. E. ; Fraser, G. A. M....
Hematological Oncology. 41 (2023) S2 - p. 461-463 , 2023

Link: https://doi.org/10.1002/..

9

Zanubrutinib safety/tolerability profile and comparison wit..:

Brown, J. R. ; Eichorst, B. ; Ghia, P....
Hematological Oncology. 41 (2023) S2 - p. 459-461 , 2023

Link: https://doi.org/10.1002/..

10

P475 RECURRENT CORONARY ARTERY VASOSPASM COMPLICATED BY CAR..:

Tedeschi, A ; Palazzini, M ; Gentile, P...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D229-D230 , 2023

Link: https://doi.org/10.1093/..

11

EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PH..:

Frustaci, A. M. ; Montillo, M. ; Rossi, D....
Hematological Oncology. 41 (2023) S2 - p. 62-63 , 2023

Link: https://doi.org/10.1002/..

12

Long‐term efficacy and safety of zanubrutinib (ZANU) in rel..:

Trotman, J. ; Tedeschi, A. ; Hu, B....
Hematological Oncology. 41 (2023) S2 - p. 390-392 , 2023

Link: https://doi.org/10.1002/..

13

RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE I..:

Thieblemont, C. ; Lamy, T. ; Tani, M....
Hematological Oncology. 41 (2023) S2 - p. 104-106 , 2023

Link: https://doi.org/10.1002/..

14

ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN..:

Shadman, M. ; Munir, T. ; Roback, T....
Hematological Oncology. 41 (2023) S2 - p. 235-238 , 2023

Link: https://doi.org/10.1002/..

15

Predicting body composition of hair-lambs basedon body mass..:

Salazar-Cuytun, E. ; Sarmiento-Franco, L. ; Aguilar-Caballero, A...
Journal of Animal and Feed Sciences. 31 (2022) 3 - p. 283-291 , 2022

Link: https://doi.org/10.22358..